131 related articles for article (PubMed ID: 38491173)
1. Prognostic factors of renal cell cancer in elderly patients: a population-based cohort study.
Pajunen H; Veitonmäki T; Huhtala H; Nikkola J; Pöyhönen A; Murtola T
Sci Rep; 2024 Mar; 14(1):6295. PubMed ID: 38491173
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma.
Smith AB; Horvath-Puhó E; Nielsen ME; Lash TL; Baron JA; Sørensen HT
Urol Oncol; 2014 May; 32(4):466-72. PubMed ID: 24767684
[TBL] [Abstract][Full Text] [Related]
3. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
Kutikov A; Egleston BL; Wong YN; Uzzo RG
J Clin Oncol; 2010 Jan; 28(2):311-7. PubMed ID: 19933918
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.
Hou Q; Wang Y; Zhang D; Luo Y; Dong L; Mu M; Yu J; Liang P
Technol Cancer Res Treat; 2023; 22():15330338231183585. PubMed ID: 38018134
[TBL] [Abstract][Full Text] [Related]
5. A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study.
Wang J; Tang J; Chen T; Yue S; Fu W; Xie Z; Liu X
J Transl Med; 2022 Feb; 20(1):90. PubMed ID: 35164796
[TBL] [Abstract][Full Text] [Related]
6. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.
Lichtensztajn DY; Hofer BM; Leppert JT; Brooks JD; Chung BI; Shah SA; DeRouen MC; Cheng I
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):202-207. PubMed ID: 36480301
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
8. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2021; 9():831940. PubMed ID: 35155365
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
13. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
14. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
15. Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study.
Horsbøl TA; Dalton SO; Christensen J; Petersen AC; Azawi N; Donskov F; Holm ML; Nørgaard M; Lund L
Acta Oncol; 2022 Jan; 61(1):58-63. PubMed ID: 34807805
[TBL] [Abstract][Full Text] [Related]
16. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.
Rosiello G; Larcher A; Fallara G; Giancristofaro C; Martini A; Re C; Cei F; Musso G; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Salonia A; Necchi A; Raggi D; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2022 Jun; 40(6):271.e19-271.e27. PubMed ID: 35140049
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
19. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
[TBL] [Abstract][Full Text] [Related]
20. Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study.
Falsetti L; Viticchi G; Zaccone V; Guerrieri E; Diblasi I; Giuliani L; Giovenali L; Gialluca Palma LE; Marconi L; Mariottini M; Fioranelli A; Moroncini G; Pansoni A; Burattini M; Tarquinio N
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
